Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxabact in Primary Hyperoxaluria
NCT02012985Phase 2Completed
- Sponsor
- OxThera AB
- Start
- Dec 2013
- Primary completion
- Jan 2015
- Modality
- Live Biotherapeutic Products
- Countries
- 3
01
Overview
A Phase 2 trial of oxalobacter formigenes in Primary hyperoxaluria (PH), sponsored by OxThera AB. Started Dec 2013; status: completed.
02
Drugs
oxalobacter formigenes
03
Conditions
Primary hyperoxaluria (PH)
Beyond the preview
Go deeper on NCT02012985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02012985.